Bachem Whitepaper – Maintaining Resilient TIDES Supply in a VUCA World

Leading CDMO Bachem AG has published a whitepaper showing how it is possible to maintain steady supplies of peptides and oligonucleotides in a world dominated by volatility, uncertainty, complexity, and ambiguity.

VUCA is an acronym that came into general use from the early 1990s, reflecting the more complex multilateral world resulting from the end of the Cold War. It now provides a framework within which organizations can assess their challenges and opportunities, emphasizing strategic foresight, insight, and highlighting the systemic and behavioral failures that can result from organizational failures. 

A Global Strain on Supply Chains

The Bachem whitepaper Maintaining a resilient TIDES supply chain under VUCA conditions explores the challenges involved in ensuring a reliable pharmaceutical supply chain under current volatile world conditions associated with the COVID pandemic, increased geopolitical tensions, and environmental stresses. 

The technical article identifies the innovative strategies and technologies that enable consistent TIDES-based API production despite global disruptions. It explains how Bachem navigates these challenges to deliver high-quality medications consistently, safeguarding patient health worldwide.

Technology and Integration 

The whitepaper Maintaining a resilient TIDES supply chain under VUCA conditions is available for download from Bachem now. 

The first part of the paper traces Global Disruptions: the impact of events like COVID-19 on pharmaceutical supply chains.

Subsequent sections detail: 

• Resilience Strategies: The importance of visibility, flexibility, collaboration, and control.
• Technological Advancements: Use of predictive analytics and blockchain for better traceability.
• Integrated approach: Bachem’s combination of in-house manufacturing and strong supplier partnerships for quality control.

Resources

Click on Bachems News to see latest News & Events.